Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heddle

Showing results (191-200 of 204) with videos related to

Pageof 21
Sort By:
JAMA|October 13, 2016
Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and StorageJeffrey L Carson, Gordon Guyatt, Nancy M Heddle, et al.
The New England Journal of Medicine|October 25, 2016
Effect of Short-Term vs. Long-Term Blood Storage on Mortality after TransfusionNancy M Heddle, Richard J Cook, Donald M Arnold, et al.
The Lancet. Haematology|August 28, 2020
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trialDonald M Arnold, Nancy M Heddle, Richard J Cook, et al.
The Lancet. Haematology|October 13, 2017
Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trialRichard J Cook, Nancy M Heddle, Ker-Ai Lee, et al.
Transfusion Medicine Reviews|December 15, 2015
Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized TrialJohn W Eikelboom, Richard J Cook, Rebecca Barty, et al.
JAMA|October 22, 2019
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical TrialJeannie Callum, Michael E Farkouh, Damon C Scales, et al.
Blood Advances|May 9, 2022
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopeniaJason B Giles, Heidi E Steiner, Jerome Rollin, et al.
Transfusion|March 10, 2018
Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine CommitteeMelissa M Cushing, James Kelley, Ellen Klapper, et al.
Blood|April 4, 2022
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopeniaJason H Karnes, Jerome Rollin, Jason B Giles, et al.
Blood|May 19, 2018
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trialPieter F van der Meer, Paula F Ypma, Nan van Geloven, et al.
Pageof 21

Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
JAMA|October 13, 2016
Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and StorageJeffrey L Carson, Gordon Guyatt, Nancy M Heddle, et al.
The New England Journal of Medicine|October 25, 2016
Effect of Short-Term vs. Long-Term Blood Storage on Mortality after TransfusionNancy M Heddle, Richard J Cook, Donald M Arnold, et al.
The Lancet. Haematology|August 28, 2020
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trialDonald M Arnold, Nancy M Heddle, Richard J Cook, et al.
The Lancet. Haematology|October 13, 2017
Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trialRichard J Cook, Nancy M Heddle, Ker-Ai Lee, et al.
Transfusion Medicine Reviews|December 15, 2015
Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized TrialJohn W Eikelboom, Richard J Cook, Rebecca Barty, et al.
JAMA|October 22, 2019
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical TrialJeannie Callum, Michael E Farkouh, Damon C Scales, et al.
Blood Advances|May 9, 2022
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopeniaJason B Giles, Heidi E Steiner, Jerome Rollin, et al.
Transfusion|March 10, 2018
Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine CommitteeMelissa M Cushing, James Kelley, Ellen Klapper, et al.
Blood|April 4, 2022
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopeniaJason H Karnes, Jerome Rollin, Jason B Giles, et al.
Blood|May 19, 2018
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trialPieter F van der Meer, Paula F Ypma, Nan van Geloven, et al.
Pageof 21